Loading...
Back to narrative

THRM: Future Revenue Range Expansion Will Likely Drive Share Price Higher

Update shared on 08 Nov 2025

Fair value Increased 0.88%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-15.6%
7D
-1.2%

Analysts Slightly Raise Gentherm Price Target to $45.60

Analysts have modestly increased their price target for Gentherm from $45.20 to $45.60, citing incremental improvements in revenue growth estimates and updated valuation assumptions.

What's in the News

  • Gentherm has raised its earnings guidance for the full year 2025, now expecting product revenues between $1.47 billion and $1.49 billion. This compares to the previous estimate of $1.43 billion to $1.5 billion. (Key Developments)

Valuation Changes

  • Fair Value: Increased slightly from $45.20 to $45.60 per share.
  • Discount Rate: Rose modestly, moving from 8.30% to 8.91%.
  • Revenue Growth: Adjusted upward marginally from 3.00% to 3.02% annually.
  • Net Profit Margin: Remained stable, with a minimal change from 7.15% to 7.15%.
  • Future P/E: Increased slightly from 14.50x to 14.88x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.